263 related articles for article (PubMed ID: 24510719)
1. Overview of experimental models of the blood-brain barrier in CNS drug discovery.
Palmer AM; Alavijeh MS
Curr Protoc Pharmacol; 2013 Oct; 62():7.15.1-7.15.30. PubMed ID: 24510719
[TBL] [Abstract][Full Text] [Related]
2. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
3. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
Ohtsuki S; Terasaki T
Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
Abbott NJ
J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
[TBL] [Abstract][Full Text] [Related]
5. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
Wang Q; Zuo Z
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
[TBL] [Abstract][Full Text] [Related]
6. Demystifying brain penetration in central nervous system drug discovery. Miniperspective.
Di L; Rong H; Feng B
J Med Chem; 2013 Jan; 56(1):2-12. PubMed ID: 23075026
[TBL] [Abstract][Full Text] [Related]
7. New experimental models of the blood-brain barrier for CNS drug discovery.
Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
[TBL] [Abstract][Full Text] [Related]
8. Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2).
Nicolazzo JA; Katneni K
Curr Top Med Chem; 2009; 9(2):130-47. PubMed ID: 19200001
[TBL] [Abstract][Full Text] [Related]
9. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.
Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A
Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632
[TBL] [Abstract][Full Text] [Related]
10. ABC transporters and drug efflux at the blood-brain barrier.
Shen S; Zhang W
Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
[TBL] [Abstract][Full Text] [Related]
11. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
12. The blood-brain barrier: bottleneck in brain drug development.
Pardridge WM
NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
[TBL] [Abstract][Full Text] [Related]
13. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates.
Adenot M; Lahana R
J Chem Inf Comput Sci; 2004; 44(1):239-48. PubMed ID: 14741033
[TBL] [Abstract][Full Text] [Related]
15. Application of an in vivo brain microdialysis technique to studies of drug transport across the blood-brain barrier.
Deguchi Y; Morimoto K
Curr Drug Metab; 2001 Dec; 2(4):411-23. PubMed ID: 11766991
[TBL] [Abstract][Full Text] [Related]
16. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
17. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier.
Gumbleton M; Audus KL
J Pharm Sci; 2001 Nov; 90(11):1681-98. PubMed ID: 11745727
[TBL] [Abstract][Full Text] [Related]
18. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
de Lange EC; Hammarlund-Udenaes M
Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds.
Alavijeh MS; Palmer AM
Neurobiol Dis; 2010 Jan; 37(1):38-47. PubMed ID: 19818851
[TBL] [Abstract][Full Text] [Related]
20. Transporter-mediated permeation of drugs across the blood-brain barrier.
Tamai I; Tsuji A
J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]